Short Interest in Fresenius SE & Co. (OTCMKTS:FSNUY) Increases By 2,262.6%

Fresenius SE & Co. (OTCMKTS:FSNUY) saw a significant increase in short interest in the month of December. As of December 15th, there was short interest totaling 98,734 shares, an increase of 2,262.6% from the November 30th total of 4,179 shares. Based on an average daily trading volume, of 170,340 shares, the days-to-cover ratio is presently 0.6 days. Based on an average daily trading volume, of 170,340 shares, the days-to-cover ratio is presently 0.6 days.

Fresenius SE & Co. Stock Performance

Shares of OTCMKTS FSNUY traded up $0.11 during midday trading on Wednesday, hitting $14.40. The company’s stock had a trading volume of 16,185 shares, compared to its average volume of 51,310. The business’s fifty day simple moving average is $14.81 and its two-hundred day simple moving average is $13.68. The company has a current ratio of 1.26, a quick ratio of 0.99 and a debt-to-equity ratio of 0.49. Fresenius SE & Co. has a 1 year low of $8.58 and a 1 year high of $33.93.

Fresenius SE & Co. (OTCMKTS:FSNUY) last announced its earnings results on Wednesday, November 5th. The company reported $0.23 earnings per share for the quarter, topping the consensus estimate of $0.21 by $0.02. Fresenius SE & Co. had a net margin of 5.26% and a return on equity of 9.72%. The firm had revenue of $6.29 billion for the quarter, compared to the consensus estimate of $6.38 billion. Research analysts anticipate that Fresenius SE & Co. will post 0.79 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on FSNUY shares. Morgan Stanley reissued an “overweight” rating on shares of Fresenius SE & Co. in a research note on Monday, December 15th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Fresenius SE & Co. in a research report on Monday, October 27th. Two research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company has a consensus rating of “Buy”.

Fresenius SE & Co. Company Profile

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.